Nice Report CLQ, page-67

First 67 Last

Share
Profile

Follow
Hotrock1

1,976 Posts.

580

18/10/17

10:09

Post #: 27989496
Share

Originally posted by laser1 ↑

Seems AUZ share price set to double, with this explanation by the company:

"3. If the answer to question 1 is “no”, is there any other explanation that AUZ may have for the recent trading in its securities?
Australian Mines’ Managing Director, Benjamin Bell, is currently participating in the 121 Mining Investment conference in Hong Kong, where he is holding general briefing sessions with current and potential investors based on information already disclosed to the market.
Australian Mines notes that Macquarie Research, part of Macquarie Bank Limited, recently announced a 12-month price target of $2.10 for Clean TeQ Holding Limited, which would value their sole mining asset (being the Syerston Project) at $1.2 billion. As the Company has reported to the market (via the ASX platform), including most recently on 6 September 2017, Australian Mines’ Sconi Project is similar to Clean TeQ Holding’s Syerston Project including in terms of their resource tonnage, expected cobalt- nickel-scandium feed grade, geology, metallurgy and expected metal recoveries. Despite Australian Mines’ Sconi Project and Clean TeQ’s Syerston project being very similar, Australian Mines’ market capitalisation is currently about 10% of Clean TeQ Holdings.
The significant disparity between Australian Mines and Clean TeQ’s market capitalisation appears to have created an arbitrage situation whereby investors can gain exposure to the cobalt-nickel market via Australian Mines at a material discount to its peers.
Based on discussions with investors attending the 121 Mining Investment conference in Hong Kong, it is this disparity in the two companies’ market capitalisations that is attracting new investors into Australian Mines (and for current shareholders to accumulate more AUZ stock), which in turn could explain the significant increase in the volume of Australian Mines’ securities traded today as well as the increase in the price of AUZ’s securities from an opening price of $0.025 to a closing price of $0.034 today (Tuesday, 17 October 2017)."

No mention of PGM in response but why should there be? Both CLQ and AUZ are receiving favourable market press over their positive actions. We are off everyone's radar and look like staying that way.

Buyers down on PGM this morning. hopefully the optimism expressed in grand statements made here will be justified by PGM's actions sooner rather than later.

Expand

Last sale 16 cents nearly 1M shares trade .. solid buying

PGM Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

The iron ore comeback: Can it last?

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

HAS

Hastings progressing Yangibana to production with lower costs

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 16 more messages in this thread...

First 67 Last

Add PGM (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $13.08M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$2.304K	109.1K

Buyers (Bids)

No.	Vol.	Price($)
2	450000	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	1352	1

View Market Depth

No.	Vol.	Price($)
2	450000	0.020
1	256355	0.019
2	375600	0.018
3	326465	0.017
1	250000	0.016

Price($)	Vol.	No.
0.021	1352	1
0.022	1260609	3
0.023	702783	4
0.024	52649	1
0.026	55555	1

Last trade - 16.10pm 30/09/2024 (20 minute delay)

PGM (ASX) Chart

Nice Report CLQ, page-67

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Hastings progressing Yangibana to production with lower costs

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nice Report CLQ, page-67

Top Stories

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Hastings progressing Yangibana to production with lower costs

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News